Form 4: Core Laboratories Inc. Executive Reports Stock Transactions

A Form 4 filing reveals that Core Laboratories Inc.'s CAO & Treasurer, Teo Sow Hang, engaged in stock transactions involving the acquisition and disposal of common stock and restricted shares.

Summary

• Teo Sow Hang, CAO & Treasurer of Core Laboratories Inc., filed a Form 4 detailing changes in beneficial ownership.
• On December 1, 2024, 227 shares of common stock were disposed of at a price of $20.42 per share.
• Also on December 1, 2024, 576 shares of common stock were acquired at a price of $0 per share.
• Additionally, 576 restricted shares were acquired on the same date.
• Following these transactions, Teo Sow Hang beneficially owns 7,639.334 shares of common stock and 8,419 restricted shares.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing of stock transactions, which is neither positive nor negative in itself. It reflects standard executive compensation practices.

Industry Context

This filing is a routine disclosure of insider transactions, which is a common practice for publicly traded companies. It provides transparency into the trading activities of company executives.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the United States, as mandated by the Securities and Exchange Commission (SEC).
• The reporting requirements are consistent across all companies, ensuring transparency in insider trading activities.
• Similar filings are made by executives at companies like Schlumberger (SLB) and Halliburton (HAL), which are also in the oilfield services sector.

Stakeholder Impact

• The transactions have a minimal direct impact on shareholders, as they are part of standard executive compensation practices.
• The filing provides transparency to the market regarding insider trading activities.

Key Dates

Keywords

Form 4, insider trading, stock transactions, beneficial ownership, Core Laboratories Inc., CLB, restricted shares, common stock